KDM6A and cancer: Furthermore, H3K27me3 has been proposed to ‘pre-mark’ genes for de novo methylation in cancer by favoring the aberrant recruitment of DNA methyltransferases [53], which suggests that KDM6A mutations may play an important role for the establishment of CIMP.